Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.59 |
| ▸ | HPGD | P15428 | 2/20 | 0.55 |
| ▸ | CA1 | P00915 | 2/20 | 0.55 |
| ▸ | CA2 | P00918 | 2/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.55 |
| ▸ | CA6 | P23280 | 1/20 | 0.55 |
| ▸ | CA9 | Q16790 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | PTPRC | P08575 | 2/20 | 0.53 |
| ▸ | CTSL | P07711 | 1/20 | 0.53 |
| ▸ | PTPN13 | Q12923 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.51 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.51 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.51 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29395845 | 1.00 | KDM4E (0.62) | KDM4EALDH1A1EGLN2HPGDCA1 | |
| SCHEMBL29238224 | 0.98 | KDM4E (0.61) | KDM4EALDH1A1EGLN2HPGDCA1 | |
| Benzoic Acid SCHEMBL15670727 | 0.94 | CA12 (0.58) | KDM4EALDH1A1EGLN2HPGDCA1 | |
| SCHEMBL1840451 | 0.89 | KDM4E (0.60) | KDM4EALDH1A1HPGDCA1CA2 | |
| SCHEMBL29780425 | 0.84 | KDM4E (0.56) | KDM4EALDH1A1HPGDCA1CA2 | |
| SCHEMBL23484191 | 0.83 | KDM4E (0.69) | KDM4EALDH1A1EGLN2CA1CA2 | |
| SCHEMBL3197946 | 0.83 | KDM4E (0.59) | KDM4EALDH1A1EGLN2HPGDCA1 | |
| SCHEMBL7443371 | 0.83 | ALDH1A1 (0.54) | KDM4EALDH1A1EGLN2CA1CA2 | |
| Hippuric Acid SCHEMBL8957458 | 0.81 | HIF1A (0.59) | KDM4ECA1CA2SMN1; SMN2PTPRC | |
| SCHEMBL1285808 | 0.81 | NPC1 (0.63) | KDM4EALDH1A1HPGDSMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 270 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3869192-B1 | METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE | HUMAN METABOLOMICS INST INC (CN) | 2026-05-13 | — | — | EP | claimed |
| US-20250258146-A1 | QUANTITATIVE DETECTION METHOD OF MULTIPLE METABOLITES IN BIOLOGICAL SAMPLE AND METABOLIC CHIP | HUMAN METABOLOMICS INSTITUTE INC. (CN) | 2025-08-14 | — | — | US | claimed |
| CN-119555822-A | Urine metabolism marker composition for diagnosis of cancer seeds of pan-cancer, screening method and application | 哈尔滨脉图精准技术有限公司 | 2025-03-04 | — | — | CN | claimed |
| US-20250051551-A1 | IMPROVED POLYMER COMPOSITES | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2025-02-13 | — | — | US | claimed |
| CN-119291059-A | Screening method for metabolic markers for distinguishing non-colorectal cancer diseases from colorectal cancer and application of screening method | 哈尔滨脉图精准技术有限公司 | 2025-01-10 | — | — | CN | claimed |
| US-20240230622-A9 | Methods and Systems for Determining Autism Spectrum Disorder Risk | LABORATORY CORPORATION OF AMERICA HOLDINGS (US) | 2024-07-11 | — | — | US | claimed |
| CN-118084715-A | 3-Hydroxy hippuric acid derivative, 3-hydroxy hippuric acid immunodetection reagent and preparation method thereof | 合肥爱索特克医学检验实验室有限公司 | 2024-05-28 | — | — | CN | claimed |
| US-20240133865-A1 | Methods and Systems for Determining Autism Spectrum Disorder Risk | LABORATORY CORPORATION OF AMERICA HOLDINGS (US) | 2024-04-25 | — | — | US | claimed |
| US-20240019417-A1 | Methods and Systems for Determining Autism Spectrum Disorder Risk | LABORATORY CORPORATION OF AMERICA HOLDINGS (US) | 2024-01-18 | — | — | US | claimed |
| WO-2023185709-A1 | MARKER COMBINATION FOR DIAGNOSING ADVANCED COLORECTAL TUMOR, AND APPLICATION THEREOF | 武汉迈特维尔医学科技有限公司 | 2023-10-05 | — | — | WO | claimed |
| US-20150293072-A1 | METHODS AND SYSTEMS FOR DETERMINING AUTISM SPECTRUM DISORDER RISK | LABORATORY CORPORATION OF AMERICA HOLDINGS | 2015-10-15 | — | — | US | claimed |
| WO-2015157601-A1 | METHODS AND SYSTEMS FOR DETERMINING AUTISM SPECTRUM DISORDER RISK | SYNAPDX CORPORATION (US) | 2015-10-15 | — | — | WO | claimed |
| US-20150065366-A1 | Biomarkers for Bladder Cancer and Methods Using the Same | METABOLON, INC. | 2015-03-05 | — | — | US | claimed |
| CN-104204798-A | Biomarkers for bladder cancer and methods using the same | METABOLON INC | 2014-12-10 | — | — | CN | claimed |
| EP-2776832-A1 | BIOMARKERS FOR BLADDER CANCER AND METHODS USING THE SAME | Metabolon, Inc. (US) | 2014-09-17 | — | — | EP | claimed |
| WO-2013188333-A1 | BIOMARKERS RELATED TO NEPHROTOXICITY AND METHODS USING THE SAME | METABOLON, INC. (US) | 2013-12-19 | — | — | WO | claimed |
| US-20130234071-A1 | COMPOSITION OF HUMAN SYNTHETIC URINE | DENEAU JOEL DAVID (US) | 2013-09-12 | — | — | US | claimed |
| WO-2013070839-A1 | BIOMARKERS FOR BLADDER CANCER AND METHODS USING THE SAME | METABOLON, INC. (US) | 2013-05-16 | — | — | WO | claimed |
| WO-2013048344-A1 | URINARY METABOLOMIC MARKERS FOR RENAL INSUFFICIENCY | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2013-04-04 | — | — | WO | claimed |
| US-20120040383-A1 | Methods and Kits Relating To Metabolite Biomarkers For Colorectal Cancer | THE UNIVERSITY OF NORTH CAROLINA AT GREENSBORO | 2012-02-16 | — | — | US | claimed |